Activation of c-Src is inversely correlated with biological aggressiveness of breast carcinoma

Breast Cancer Research and Treatment

Volumn 76, Issue 3, 2002, Pages 261-267

  Ito, Yasuhiro ^a,b   Kawakatsu, Hisaaki ^c   Takeda, Tsutomu ^a   Tani, Naoyuki ^b   Kawaguchi, Naomasa ^b   Noguchi, Shinzaburo ^d   Sakai, Takao ^e   Matsuura, Nariaki ^b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^e LUND UNIVERSITY   (Sweden)

Author keywords

Breast carcinoma; Immunohistochemistry; Src

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN KINASE P60;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MAMMARY GLAND; MYOEPITHELIUM CELL; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; STROMA CELL; TUMOR VOLUME; WESTERN BLOTTING; BREAST; BREAST TUMOR; CANCER INVASION; CELL TRANSFORMATION; ENZYME ACTIVATION; EPITHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY;

ADULT; AGED; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL TRANSFORMATION, NEOPLASTIC; ENZYME ACTIVATION; EPITHELIAL CELLS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS PP60(C-SRC);

EID: 0036890288     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020860221099     Document Type: Article

References (39)

1. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990
2. Bolen JB, Rosen N, Israel MA: Increased pp60c-src tyrosyl kinase activity in human neuroblastomas is associated with amino-terminal tyrosine phosphorylation of the src gene product. Proc Natl Acad Sci USA 82: 7275-7279, 1985
3. Jacobs C, Rubsamen H: Expression of pp60c-src protein kinase in adult and fetal human tissue: High activities in some sarcomas and mammary carcinomas. Cancer Res 43: 1696-1702, 1983
4. Masaki T, Okada M, Shiratori Y, Rengifo W, Matsumoto K, Maeda S, Kato N, Kanai F, Komatsu Y, Nishioka M, Omata M: pp60c-src activation in hepatocellular carcinoma of humans and LEC rats. Hepatology 27: 1257-1264, 1998
5. Bolen JB, Veillette A, Schwartz AM, DeSeau V, Rosen N: Activation of pp60c-src protein kinase activity in human colon carcinoma. Proc Natl Acad Sci USA 84: 2251-2255, 1987
6. Cartwright CA, Meisler AI, Eckhart W: Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis. Proc Natl Acad Sci USA 87: 558-562, 1990
7. c-src in progressive stages of human colorectal cancer. J Clin Invest 91: 53-60, 1993
8. Sakai T, Kawakatsu H, Fujita M, Yano J, Owada MK: An epitope localised in c-Src negative regulatory domain is a potential marker in early stage of colonic neoplasms. Lab Invest 78: 219-225, 1998
9. Iravani S, Mao W, Fu L, Karl R, Yeatman T, Jove R, Cappola D: Elevated c-src protein expression is an early event in colonic neoplasia. Lab Invest 78: 365-371, 1998
10. Yamamoto H, Monden T, Ikeda K, Izawa H, Fukuda K, Fukunaga M, Tomita N, Shimano T, Shiozaki H, Monden M: Coexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer. Br J Cancer 71: 1231-1236, 1995
11. Kawakatsu H, Sakai T, Takagaki Y, Shinoda M, Saito M, Owada MK, Yano J: A new monoclonal antibody which selectively recognises the active form of c-Src tyrosine kinase. J Biol Chem 271: 5680-5685, 1996
12. Sasaki K, Murakami T, Kawasaki M: The cell cycle associated change of the Ki-67 reactive nuclear antigen expression. J Cell Physiol 133: 579-584, 1987
13. Tseng H, Petersson TE, Berk BC: Fluid shear stress stimulates mitogen-activated protein kinase in endothelial cells. Circ Res 77: 869-878, 1995
14. Kostin S, Hein S, Bauer EP, Schaper J: Spatiotemporal development and distribution of intercellular junctions in adult rat cardiomyocytes in culture. Circ Res 85: 154-167, 1999
15. Sobin LH, Wittekind C: Classification of Malignant Tumours. 5th Edn, 1997
16. Kypta RM, Boldberg Y, Ulug ET, Courtneidge SA: Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell 62: 481-492, 1990
17. Courtneidge SA, Dhand R, Pilat D, Twamly GM, Waterfield MD, Roussel MF: Activation of src-family kinases by CSF-1 and their association with the receptor. EMBO J 12: 943-950, 1993
18. Oude Weemink PA, Ottenhoff-Kalff AE, Vendrig MP, van Beurden EACM, Stgaal GEJ, Rijksen G: Functional interaction between the epidermal growth factor receptor and c-src kinase activity. FEBS Lett 352: 296-300, 1994
19. Oshrev N, Levitzki A: Epidermal-growth-factor-dependent activation of the src-family kinases. Eur J Biochem 225: 1047-1053, 1994
20. Muthuswamy SK, Siegel PM, Dankort DL, Webster MA, Muller WJ: Mammary tumors expressing the neu protooncogenes possess elevated c-src tyrosine kinase activity. Mol Cell Biol 14: 735-743, 1994
21. Sheffield LG: C-Src activation by ErbB2 leads to attachment-independent growth of human breast epithelial cells. Biochem Biophys Res Commun 250: 27-31, 1998
22. Coltrera MD, Wang J, Porter PL, Gown AM: Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma. Cancer Res 55: 2703-2708, 1995
23. Flick MB, Sapi E, Perrotta PI, Maher MG, Halaban R, Carter D, Kacinski BM: Recognition of activated CSF-1 receptor in breast carcinomas by a tyrosine 723 phosphospecific antibody. Oncogene 14: 2553-2561, 1997
24. Kacinski BM, Scata KA, Carter D, Yee LD, Sapi E, King BL, Chambers SK, Jones MA, Pirro MH, Stanley ER: FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro. Oncogene 6: 941-952, 1991
25. Slamon DJ, Clark GM, Song SG, Leven WJ, Ullrich A, McGuire WL: Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/Neu oncogene. Science 235: 177-182, 1987
26. Macias A, Azavedo E, Hagerstrom T, Klintenberg C, Perez R, Skoog L: Prognostic significance of the receptor for epidermal growth factor in human mammary carcinomas. Anticancer Res 7: 459-464, 1987
27. Spyratos F, Hacene K, Tabiana-Hulin M, Pallud C, Brunet M: Prognostic value of estrogen and progesterone receptors in primary infiltrating ductal breast cancer. A Sequential multivariate analysis of 1262 patients. Eur J Cancer Clin Oncol 1989: 25: 1233-124.
28. Williams MR, Todd JH, Ellis IO, Dowle CS, Haybittle JL, Elston CW, Nicholson RI, Griffiths K, Blamey RW: Oestrogen receptors in primary and advanced breast cancer: An eight year review of 704 cases. Br J Cancer 1987: 55: 67-73.
29. Schroeder W, Biesterfeld S, Zillessen S, Rath W: Epidermal growth factor receptor-immunohistochemical detection and clinical significance for treatment of primary breast cancer. Anticancer Res 17: 2799-2802, 1997
30. Sainsbury JR, Farndon JR, Harris AL, Sherbet GV: Epidermal growth factor receptors on human breast cancers. Br J Surg 72: 186-188, 1985
31. Querzoli P, Marchetti E, Fabris G, Marzola A, Ferretti S, Lacobelli S, Hazan R, King CR, Nenci I: Immunohistochemical expression of c-erbB-2 in human breast cancer by monoclonal antibody: Correlation with lymph node and ER status. Tumori 76: 461-464, 1990
32. Wright C, Angus B, Nicholson S, Sainsbury JR, Cairns J, Gullick WJ, Kelly P, Harris AL, Horne CH: Expression of c-erbB-2 oncoprotein: A prognostic indicator in human breast cancer. Cancer Res 49: 2087-2090, 1989
33. Heatley M, Maxwell P, Whiteside C, Toner PG: C-erbB-2 oncogene product expression depends on tumour type and is related to oestrogen receptor and lymph node status in human breast carcinoma. Pathol Res Pract 189: 261-266, 1993
34. Kallioniemi OP, Holli K, Visakorpi T, Koivula T, Helin HH, Isola JJ: Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer. Int J Cancer 49: 650-655, 1991
35. Barbareschi M, Leonardi E, Mauri FA, Serio G, Dalla Palma P: p53 and c-erbB-2 protein expression in breast carcinoma. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer. Am J Clin Pathol 98: 408-418, 1992
36. Ottenhoff-Kalff AE, Rijiksen G, van Beurden EACM, Hannipman A, Michels AA, Staal EGJ: Characterization of protein tyrosine kinases from human breast cancer: Involvement of the c-src oncogene product. Cancer Res 52: 4773-4778, 1992
37. Verbeek BS, Vroom TM, Adriaansen-Slot SS, Ottenhoff-Kalff AE, Geertzema JGN, Hennipman A, Rijksen A: c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol 180: 383-388, 1996
38. c-src. Mol Cel Biol 6: 4467-4477, 1986
39. Lee C-H, Saksela K, Mirza UA, Chait BT, Kuriyan J: Crystal structure of the conserved core of HIV: Nef complexed with a src family SH3 domain. Cell 85: 931-942, 1996